The University of Chicago Header Logo

Connection

Suzanne Conzen to Sirolimus

Back to Details
This is a "connection" page, showing publications Suzanne Conzen has written about Sirolimus.
Suzanne Conzen
Connection Strength
0.186
Sirolimus
  1. Serum and glucocorticoid-regulated kinase 1 (SGK1) activation in breast cancer: requirement for mTORC1 activity associates with ER-alpha expression. Breast Cancer Res Treat. 2012 Sep; 135(2):469-79.
    View in: PubMed
    Score: 0.095
  2. Phase II trial of temsirolimus in patients with metastatic breast cancer. Breast Cancer Res Treat. 2012 Nov; 136(2):355-63.
    View in: PubMed
    Score: 0.091
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.